Cargando…

Marked paper: Type 2 diabetes mellitus indicates increased postoperative complications and poor prognosis in colorectal cancer patients receiving curative surgery

PURPOSE: This study aimed to evaluate the impact of type 2 diabetes mellitus (T2DM) on the short-term outcomes and long-term survival of patients with colorectal cancer (CRC) who underwent curative resection. METHODS: This study retrospectively included 136 patients (T2DM group) with resectable CRC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Daoli, Zhang, Xubing, Zhou, Hong, Zhu, Zhiqiang, He, Yiren, Wan, Xiao, Zhang, Bo, Liu, Shaojun, Liu, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947490/ https://www.ncbi.nlm.nih.gov/pubmed/36845740 http://dx.doi.org/10.3389/fonc.2023.1128383

Ejemplares similares

Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection
por: Peng, Ke, et al.
Publicado: (2022)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Postoperative fever predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Curated Collections for Educators: Five Key Papers about Receiving Feedback in Medical Education
por: Natesan, Sreeja, et al.
Publicado: (2019)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer
por: Kang, Yue, et al.
Publicado: (2015)

High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection
por: Sun, Jialei, et al.
Publicado: (2019)

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
por: Liu, Furong, et al.
Publicado: (2012)

High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020)

Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis
por: Deng, Mingming, et al.
Publicado: (2020)

Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection
por: Li, Dezhi, et al.
Publicado: (2018)

Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma
por: Yi, Xiuling, et al.
Publicado: (2020)

Circular RNA circ_0006282 Contributes to the Progression of Gastric Cancer by Sponging miR-155 to Upregulate the Expression of FBXO22
por: He, Yiren, et al.
Publicado: (2020)

Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy
por: Ma, Youzhao, et al.
Publicado: (2023)

FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer
por: Tang, Qingyun, et al.
Publicado: (2022)

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015)

Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment
por: Shi, Yanan, et al.
Publicado: (2022)

Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma
por: Chu, Chenghao, et al.
Publicado: (2023)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

Elevated red blood cell distribution width contributes to poor prognosis in patients undergoing resection for nonmetastatic rectal cancer
por: Zhang, Xubing, et al.
Publicado: (2018)

Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer
por: Li, Man, et al.
Publicado: (2014)

High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma
por: Guo, Qingbao, et al.
Publicado: (2023)

FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma
por: Liao, Qingyun, et al.
Publicado: (2023)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients
por: Cheng, Jingping, et al.
Publicado: (2021)

Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study
por: Liu, Bin, et al.
Publicado: (2018)

Nerve invasion as an independent predictor of poor prognosis in gastric cancer after curative resection
por: Li, Chunsheng, et al.
Publicado: (2022)

HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case–control study
por: Li, Zhonghu, et al.
Publicado: (2016)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy
por: Dai, Kun, et al.
Publicado: (2015)

Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma
por: Shi, Chao, et al.
Publicado: (2019)

TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis via EMT Signaling Pathway
por: Shou, Yi, et al.
Publicado: (2022)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
por: Long, Hui, et al.
Publicado: (2020)

Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer
por: Zhang, Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqcosif30jdprf8nel4kbagv59